This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (31)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

A Multicenter Study

Multicenter Study Group

JAMA. 1992;267(19):2609-2615.

Abstract
Objective.
—To assess the efficiency, reliability, and ease of use of DNA diagnosis for Duchenne and Becker muscular dystrophies (DMD/BMD) using the polymerase chain reaction (PCR).

Design.
—DNA from the patients was screened for deletion mutations using multiplex PCR, and the results were compared with those obtained by Southern blot analysis. The PCR multiplex reaction detects nine specific "hot-spot" exons in the dystrophin gene while the Southern analysis detects 66 specific dystrophin gene restriction fragments. The multiplex reaction requires 50-fold less DNA than Southern analysis and thus is considerably more sensitive.

Setting.
—Fourteen university-affiliated and private genetic disease diagnostic laboratories.

Patients.
—Male patients with clinical signs of DMD/BMD. Cases were selected for analysis randomly, without knowledge of whether a deletion was present within the dystrophin gene.

Main Outcome Measures.
—The percentage of cases that were detectable by multiplex PCR in comparison with Southern analysis, the frequency, extent, and location of the detected deletion mutations. In some cases, duplication mutations were monitored.

Results.
—The accuracy of a single PCR multiplex amplification (nine exons) was compared with Southern analysis with 10 cDNA probes that cover the full length of the gene. The multiplex PCR analytic method detected 82% of those deletions detected by Southern analysis methods. In one of 745 analyses, the multiplex method suggested a single exon deletion, which was not confirmed by Southern analysis, representing a false-positive rate of 0.013%.

Conclusions.
—Multiplex PCR represents a sensitive and accurate method for deletion detection of 46% of all cases of DMD/BMD. The method requires 1 day for analysis, is easy to perform, and does not use radioactive tracers. As such, multiplex PCR represents an efficient and rapid method for prenatal or postnatal diagnosis of DMD/BMD.

(JAMA. 1992;267:2609-2615)

Footnotes
A complete list of the group's participants and their affiliations appears at the end of the article.

Reprint requests to The Institute for Molecular Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030 (Dr Caskey).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mutation Analysis in a Population-Based Cohort of Boys With Duchenne or Becker Muscular Dystrophy
Cunniff et al.
J Child Neurol 2009;24:425-430.
ABSTRACT  

HER-2/neu Amplification in Benign Breast Disease and the Risk of Subsequent Breast Cancer
Stark et al.
JCO 2000;18:267-267.
ABSTRACT | FULL TEXT  

Diagnosis of Duchenne/Becker muscular dystrophy and quantitative identification of carrier status by use of entangled solution capillary electrophoresis
Fortina et al.
Clin. Chem. 1997;43:745-751.
ABSTRACT | FULL TEXT  

Dystrophin and DNA Diagnosis in a Large Pediatric Muscle Clinic
Richards and Iannaccone
J Child Neurol 1994;9:162-166.
ABSTRACT  

Multiplex PCR: advantages, development, and applications.
Edwards and Gibbs
Genome Res 1994;3:S65-S75.
 

Tomorrow's Prenatal Genetic Testing: Should We Test for 'Minor' Diseases?
Strong
Arch Fam Med 1993;2:1187-1193.
ABSTRACT  

Molecular Medicine: A Spin-off From the Helix
Caskey
JAMA 1993;269:1986-1992.
ABSTRACT  

RAPID DIAGNOSIS OF MUSCULAR DYSTROPHY BY PCR
JWatch General 1992;1992:5-5.
FULL TEXT